Completion of patient recruitment in the CoolCryo® clinical trial
October 30, 2025
Medinice S.A. has completed patient recruitment for the ongoing CoolCryo® clinical trial, conducted at the Silesian Center for Heart Diseases in Zabrze and University Hospital named after Dr. A. Jurasz in Bydgoszcz.
Achieving full enrollment marks the completion of a key milestone in the project. Following a six-month follow-up and data analysis, the company will proceed with CE MDR certification which will facilitate commercialization in the European market.
CoolCryo® is an innovative cardiac cryoablation technology using liquid nitrogen to treat heart rhythm disorders.
We Care About Your Privacy
Medinice S.A. uses cookies to improve and customize users experience on our website. By selecting 'Accept', you consent to the use of all cookies that gather and use information about your interactions with our site to provide personalized content and enhance your digital experience. Please read our Privacy Policy for more information.